product description page

Management of Medication-related Osteonecrosis of the Jaw : An Issue of Oral and Maxillofacial Clinics

Management of Medication-related Osteonecrosis of the Jaw : An Issue of Oral and Maxillofacial Clinics - image 1 of 1
$98.99

about this item

Editor Salvatore Ruggiero, DMD, MD and authors review the Diagnosis, Management and Prevention of Medication-related Osteonecrosis of the Jaw. Articles will include: Osteoporosis and bone modulation therapies: indications and outcomes; Antiresorptive therapies for the treatment of malignant osteolytic bone disease; Clinical presentation and staging of antiresorptive agent-induced osteonecrosis of the jaw; Epidemiology and risk factors of antiresorptive agent-induced osteonecrosis of the jaw; Basic science research of antiresorptive agent-induced osteonecrosis of the jaw: an update; Pathophysiology of antiresorptive agent-induced osteonecrosis of the jaw: what we know and what we don't know; The genetics of osteonecrosis of the jaw; Preventive strategies for patients at risk of antiresorptive agent-induced osteonecrosis of the jaw; Non-operative and operative therapies for treatment of antiresorptive agent-induced osteonecrosis of the jaw; The role of anti-angiogenic therapy in the development of osteonecrosis of the jaw; Antiresorptive therapies: what they are and how do they work, and more!
Genre: Medical
Sub-Genre: Dentistry / Oral Surgery
Series Title: The Clinics: Surgery
Format: Hardcover
Publisher: Elsevier Science Health Science
volume number: 27.0
Author: Salvatore L. Ruggiero
Language: English
Street Date: November 2, 2015
TCIN: 51153446
UPC: 9780323413466
Item Number (DPCI): 248-16-4114

guest reviews

Prices, promotions, styles and availability may vary by store & online. See our price match guarantee. See how a store is chosen for you.